FEATURES OF IMMUNOPATHOGENESIS AND EVALUATION OF CLINICAL-IMMUNOLOGICAL EFFICACY OF ANTIRETROVIRAL THERAPY IN HIV-ASSOCIATED PATIENTSWITHOUT AND WITH TUBERCULOUS LYMPHADENOPATHY